Bristol-Myers Squibb Company (BMY) · page 3 of 16
This is page 3 of a shareholder letter, likely from an activist investor (Starboard Value or similar) opposing the BMY-Celgene merger.
Shareholder letter · key_messages · diagnose_problem · balanced density
Slide locked Sign in to view
Slide schematic 3/3
list 1/1 paragraph 1/1 title 1/1
Components 3
numbered paragraph action-title
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1